Read news as it happens
Create a Rediffmail account
Subscribe via RSS
After 15 years, Ranjit Shahani steps down as Novartis' India chief
The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......
Why price cap on drugs is counter productive
To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters, says Ranjit Shahani. India is the fourth fastest growing economy in......
Winning spree intact; Sensex, Nifty soar 5% in 3 sessions
Markets gained for the fourth straight session with Nifty settling above the 8,150 levels comfortably supported by sustained buying across the board especially the index heavyweights like......
Court bars Cipla from selling copy of Novartis respiratory drug
The Delhi High Court has barred generic drugmaker Cipla Ltd from making or selling a cheaper copy of Novartis AG's respiratory drug Onbrez domestically, citing infringement of patents......
NPPA slaps Rs 300-crore penalty on Novartis
Drug major Novartis has been slapped with a Rs 300-crore (Rs 3 billion) penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine. The Swiss......
bharatiya janata party
united progressive alliance
national democratic alliance
rashtriya swayamsevak sangh
central bureau of investigation
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2021 Rediff.com